SENORES PHARMACEUTICALS L (SENORES) — Cash Flow-to-Debt Ratio
SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of Rs242.20 Million could theoretically repay 0% of its total liabilities (Rs4.54 Billion) in one year. Check SENORES total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SENORES PHARMACEUTICALS L Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for SENORES PHARMACEUTICALS L across 4 annual periods. Also explore total assets of SENORES PHARMACEUTICALS L for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for SENORES PHARMACEUTICALS L (2022–2025)
Year-by-year debt coverage analysis for SENORES PHARMACEUTICALS L. For market capitalisation and broader financial context, see market value of SENORES PHARMACEUTICALS L.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -9.06x | Rs-459.20 Million | Rs50.70 Million | ▼ -13650.2% |
| 2024 | -0.07x | Rs-257.00 Million | Rs3.90 Billion | ▼ -422.3% |
| 2023 | -0.01x | Rs-10.79 Million | Rs855.54 Million | ▲ +97.3% |
| 2022 | -0.46x | Rs-104.47 Million | Rs225.62 Million | — |